Mode of action of new multiple sclerosis drug discovered

Dimethyl fumarate inhibits inflammatory cell infiltration of the central nervous system through blockade of a specific receptor. Just a few short weeks ago, dimethyl fumarate was approved in Europe as a basic therapy for multiple sclerosis. Although its efficacy has been established in clinical studies, its underlying mode of action was still unknown, but scientists from Bad Nauheim’s Max Planck …

More